Four tablespoons of extra virgin olive oil per day is the amount tested in the largest dietary trial ever run on cardiovascular outcomes in adults at high risk.
That is the dose used in PREDIMED, a Spanish randomized controlled trial of roughly 7,400 adults, published in the New England Journal of Medicine.
The Mediterranean diet arm supplemented with extra virgin olive oil reduced major cardiovascular events compared to a low-fat control diet.
The finding that matters more for women over fifty came from the same cohort. A 2015 analysis in JAMA Internal Medicine reported that women in the extra virgin olive oil arm had a significantly lower incidence of invasive breast cancer than women on the low-fat diet.
The mechanism is not just monounsaturated fat. Extra virgin olive oil contains polyphenols, particularly oleocanthal and hydroxytyrosol, which act on inflammatory pathways relevant to cardiovascular disease and hormone-sensitive cancers.
Refined oil loses most of these compounds during processing. A bottle labeled simply "olive oil" or "pure olive oil" is not the product PREDIMED tested.
The move is four tablespoons of cold-pressed extra virgin olive oil per day, used on salads, vegetables, fish, or eggs. PREDIMED participants used it as their primary culinary fat.
On the label, look for a harvest date within the last twelve months, a dark glass bottle, and a polyphenol content above 250 mg/kg when listed. That threshold is what the EU uses for its approved health claim on olive oil phenolics.
Storage matters. Heat, light, and time degrade the active compounds.
A bottle open on the counter for six months is no longer the product the trial used. Buy smaller bottles and finish them inside two to three months.
This is a kitchen decision, not a doctor's appointment. The randomized evidence for cardiovascular events and invasive breast cancer in women over fifty is stronger here than for almost any other single dietary change available to you.
